123 related articles for article (PubMed ID: 37621174)
1. Evaluation of a new technique using artificial intelligence for quantification of plasma cells on CD138 immunohistochemistry.
Gantana EJ; Nell EM; Musekwa E; Lohlun RK; Chetty C; Moodley K; Chabunya S; Ras J; Chapanduka ZC
Int J Lab Hematol; 2024 Feb; 46(1):50-57. PubMed ID: 37621174
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of an innovative new method for quantitation of plasma cells on CD138 immunohistochemistry.
Gantana E; Mashigo N; Abdullah I; Musekwa E; Lohlun R; Nell EM; Chetty C; Ntobongwana M; Chapanduka Z
J Clin Pathol; 2023 Apr; 76(4):261-265. PubMed ID: 34625512
[TBL] [Abstract][Full Text] [Related]
3. Automated digital enumeration of plasma cells in bone marrow trephine biopsies of multiple myeloma.
Malherbe JAJ; Fuller KA; Mirzai B; Augustson BM; Erber WN
J Clin Pathol; 2022 Jan; 75(1):50-57. PubMed ID: 33234694
[TBL] [Abstract][Full Text] [Related]
4. Assessment of bone marrow plasma cell infiltrates in multiple myeloma: the added value of CD138 immunohistochemistry.
Al-Quran SZ; Yang L; Magill JM; Braylan RC; Douglas-Nikitin VK
Hum Pathol; 2007 Dec; 38(12):1779-87. PubMed ID: 17714757
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of an open-source machine-learning tool to quantify bone marrow plasma cells.
Baranova K; Tran C; Plantinga P; Sangle N
J Clin Pathol; 2021 Jul; 74(7):462-468. PubMed ID: 33952591
[TBL] [Abstract][Full Text] [Related]
6. Quantification of bone marrow plasma cell infiltration in multiple myeloma: usefulness of bone marrow aspirate clot with CD138 immunohistochemistry.
Matsue K; Matsue Y; Kumata K; Usui Y; Suehara Y; Fukumoto K; Fujisawa M; Narita K; Takeuchi M
Hematol Oncol; 2017 Sep; 35(3):323-328. PubMed ID: 27140172
[TBL] [Abstract][Full Text] [Related]
7. The sensitivity of CD138 immunostaining of bone marrow trephine specimens for quantifying marrow involvement in MGUS and myeloma, including samples with a low percentage of plasma cells.
Ng AP; Wei A; Bhurani D; Chapple P; Feleppa F; Juneja S
Haematologica; 2006 Jul; 91(7):972-5. PubMed ID: 16818287
[TBL] [Abstract][Full Text] [Related]
8. CD138/syndecan-1: a useful immunohistochemical marker of normal and neoplastic plasma cells on routine trephine bone marrow biopsies.
Chilosi M; Adami F; Lestani M; Montagna L; Cimarosto L; Semenzato G; Pizzolo G; Menestrina F
Mod Pathol; 1999 Dec; 12(12):1101-6. PubMed ID: 10619261
[TBL] [Abstract][Full Text] [Related]
9. A counting strategy for estimating plasma cell number in CD138-stained bone marrow core biopsy sections.
Smith FB; Elnawawi A
Ann Clin Lab Sci; 2008; 38(2):138-42. PubMed ID: 18469359
[TBL] [Abstract][Full Text] [Related]
10. The combination of CD138/MUM1 dual-staining and artificial intelligence for plasma cell counting in the diagnosis of chronic endometritis.
Xiong Z; Zhang W; Liu S; Liu K; Wang J; Qin P; Liu Y; Jiang Q
Am J Reprod Immunol; 2023 Mar; 89(3):e13671. PubMed ID: 36544330
[TBL] [Abstract][Full Text] [Related]
11. Correlation of plasma cell percentages by CD138 immunohistochemistry, cyclin D1 status, and CD56 expression with clinical parameters and overall survival in plasma cell myeloma.
Dunphy CH; Nies MK; Gabriel DA
Appl Immunohistochem Mol Morphol; 2007 Sep; 15(3):248-54. PubMed ID: 17721267
[TBL] [Abstract][Full Text] [Related]
12. Plasma cell quantification in bone marrow by computer-assisted image analysis.
Went P; Mayer S; Oberholzer M; Dirnhofer S
Histol Histopathol; 2006 Sep; 21(9):951-6. PubMed ID: 16763944
[TBL] [Abstract][Full Text] [Related]
13. Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma.
Stifter S; Babarović E; Valković T; Seili-Bekafigo I; Stemberger C; Nacinović A; Lucin K; Jonjić N
Diagn Pathol; 2010 May; 5():30. PubMed ID: 20482792
[TBL] [Abstract][Full Text] [Related]
14. Validation of the systematic scoring of immunohistochemically stained tumour tissue microarrays using QuPath digital image analysis.
Loughrey MB; Bankhead P; Coleman HG; Hagan RS; Craig S; McCorry AMB; Gray RT; McQuaid S; Dunne PD; Hamilton PW; James JA; Salto-Tellez M
Histopathology; 2018 Aug; 73(2):327-338. PubMed ID: 29575153
[TBL] [Abstract][Full Text] [Related]
15. Bone marrow trephine combined with immunohistochemistry is superior to bone marrow aspirate in follow-up of myeloma patients.
Joshi R; Horncastle D; Elderfield K; Lampert I; Rahemtulla A; Naresh KN
J Clin Pathol; 2008 Feb; 61(2):213-6. PubMed ID: 17526802
[TBL] [Abstract][Full Text] [Related]
16. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric evaluation of bone marrow plasma cells using CD19, CD45, CD56, CD38, and CD138 and correlation with bone marrow infiltration ratio in multiple myeloma patients.
Kara IO; Sahin B; Paydas S; Cetiner S
Saudi Med J; 2004 Nov; 25(11):1587-92. PubMed ID: 15573184
[TBL] [Abstract][Full Text] [Related]
18. Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis.
Martín P; Santón A; Bellas C
Histopathology; 2004 Apr; 44(4):375-80. PubMed ID: 15049904
[TBL] [Abstract][Full Text] [Related]
19. Syndecan-1 (CD138) immunoreactivity in bone marrow biopsies of multiple myeloma: shed syndecan-1 accumulates in fibrotic regions.
Bayer-Garner IB; Sanderson RD; Dhodapkar MV; Owens RB; Wilson CS
Mod Pathol; 2001 Oct; 14(10):1052-8. PubMed ID: 11598177
[TBL] [Abstract][Full Text] [Related]
20. The cut-offs for kappa/lambda ratio in bone marrow immunohistochemistry for the diagnosis of multiple myeloma.
Warnnissorn AN; Treetipsatit J; Limvorapitak W
Hematology; 2020 Dec; 25(1):292-298. PubMed ID: 32772824
[No Abstract] [Full Text] [Related]
[Next] [New Search]
